1[1]Wanger JD, Thomas MJ, Williams JK, et al. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab 1998;83(3) :896.
2[2]Lindheim SR, Presser SC, Ditkoff EC, et al. Apossible bimodel effect of estrogen on insulin sensitivity in postemenopausul women and the attenuating effect of added progestin. Fertil Steril 1993;60(4) :664.
3[3]Collins P, Rosano GM, Jiang C, et al. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 1993;341(8855): 1264.
4[4]Nabulsi AA, Folsom AR, White A, et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine 1993; 328:1069.
5[5]Lindotedit G, Lundberg PA, Lapidus L, et al. Low sex hormone- binding globulin concentration as independent risk factor for development of NIDDM.Diabetes 1991;30(1):123.
6[6]Peiris AN, Sothmann MS, Hernes MI, et al. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis:Am Clin Nutr 1989;949(5):758.
